Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LL5V
|
|||
Former ID |
DIB020256
|
|||
Drug Name |
L-valine
|
|||
Synonyms |
L-valine; valine; 72-18-4; (S)-Valine; H-Val-OH; (S)-2-Amino-3-methylbutanoic acid; 2-Amino-3-methylbutyric acid; (2S)-2-amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutyric acid; L-alpha-Amino-beta-methylbutyric acid; Valinum [Latin]; Valina [Spanish]; Valine (VAN); Valine [USAN:INN]; Butanoic acid, 2-amino-3-methyl-; VALINE, L-; L(+)-alpha-Aminoisovaleric acid; (S)-alpha-Amino-beta-methylbutyric acid; Butanoic acid, 2-amino-3-methyl-, (S)-; 2-Amino-3-methylbutyric acid, (S)-; 2-Amino-3-methylbutanoic acid, (S)-; L-valin
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C5H11NO2
|
|||
Canonical SMILES |
CC(C)C(C(=O)O)N
|
|||
InChI |
1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1
|
|||
InChIKey |
KZSNJWFQEVHDMF-BYPYZUCNSA-N
|
|||
CAS Number |
CAS 72-18-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
3483, 595252, 833261, 841335, 3134856, 7847107, 7891042, 8025201, 8143572, 8153964, 10533892, 11528406, 14710672, 14716652, 15119814, 15218854, 17424984, 24890028, 24900695, 24900696, 24900749, 24902117, 29204662, 29225281, 46393202, 46504886, 49748671, 57323321, 57653624, 57654728, 79527381, 81044512, 83100465, 85164900, 85267077, 87350316, 87577814, 87692913, 87692918, 92297810, 96100169, 99224278, 103059097, 103059671, 103224325, 104234101, 104311628, 117365452, 117689352, 124384987
|
|||
ChEBI ID |
CHEBI:16414
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4794). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.